A Study to Evaluate the Impact of Maintaining Hemoglobin Levels Using Epoetin Alfa in Patients With Metastatic Breast Cancer Receiving Chemotherapy
Clinical trial NCT00211133 · COMPLETED
Trial details
- NCT number
- NCT00211133
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2000-06-01
- Enrollment
- 939
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.